⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6165270 | 0.70 | — | — | |
| Chloromethane SCHEMBL11788599 | 0.68 | — | — | |
| SCHEMBL11060268 | 0.67 | — | — | |
| SCHEMBL5315595 | 0.63 | TSHR (0.33) | — | |
| SCHEMBL40671 | 0.59 | — | — | |
| SCHEMBL94585 | 0.59 | — | — | |
| SCHEMBL18335409 | 0.59 | — | — | |
| SCHEMBL152843 | 0.59 | — | — | |
| SCHEMBL190299 | 0.59 | — | — | |
| SCHEMBL400906 | 0.59 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119529016-A | Method for peptide synthesis and device for carrying out a method for solid phase synthesis of peptides | 苏尔福工具股份有限公司 | 2025-02-28 | — | — | CN | disclosed |
| US-20230250113-A1 | SILIRANE-FUNCTIONALISED COMPOUNDS, IN PARTICULAR ORGANOSILICON COMPOUNDS, FOR PREPARING SILOXANES | WACKER CHEMIE AG (DE) | 2023-08-10 | — | — | US | disclosed |
| US-11466050-B2 | Method for peptide synthesis and apparatus for carrying out a method for solid phase synthesis of peptides | SULFOTOOLS GMBH (DE) | 2022-10-11 | — | — | US | disclosed |
| US-10844076-B2 | Derivatives of 6-(2,3-dichlorophenyl)-1,2,4-triazin-5-amine | NEKTAR THERAPEUTICS (US) | 2020-11-24 | — | — | US | disclosed |
| CN-111440103-A | Preparation method of tert-butyl disulfide | 爱斯特（成都）生物制药股份有限公司 | 2020-07-24 | — | — | CN | disclosed |
| US-20190071454-A1 | DERIVATIVES OF 6-(2,3-DICHLOROPHENYL)-1,2,4-TRIAZIN-5-AMINE | NEKTAR THERAPEUTICS | 2019-03-07 | — | — | US | disclosed |
| US-8288403-B2 | Heterocyclic gamma secretase modulators | HOFFMANN-LA ROCHE INC. (US) | 2012-10-16 | — | — | US | disclosed |
| US-7759499-B2 | Compounds as inhibitors of hepatitis C virus NS3 serine protease | SCHERING CORPORATION (US) | 2010-07-20 | — | — | US | disclosed |
| US-7718691-B2 | Compounds as inhibitors of hepatitis C virus NS3 serine protease | SCHERING CORPORATION (US) | 2010-05-18 | — | — | US | disclosed |
| US-20100120874-A1 | HETEROCYCLIC GAMMA SECRETASE MODULATORS | HOFFMANN-LA ROCHE, INC. | 2010-05-13 | — | — | US | disclosed |
| US-7192957-B2 | Compounds as inhibitors of hepatitis C virus NS3 serine protease | SCHERING CORPORATION (US) | 2007-03-20 | — | — | US | disclosed |
| US-20070049536-A1 | Novel compounds as inhibitors of hepatitis C virus NS3 serine protease | SCHERING CORPORATION | 2007-03-01 | — | — | US | disclosed |
| US-20070032434-A1 | used for the treatment or prevention of HCV or amelioration the symptoms of hepatitis C infection, by modulating the interaction of an HCV polypeptide with HCV proteases | SCHERING CORPORATION | 2007-02-08 | — | — | US | disclosed |
| US-20050288233-A1 | Novel compounds as inhibitors of hepatitis C virus NS3 serine protease | SCHERING CORPORATION | 2005-12-29 | — | — | US | disclosed |
| US-4281139-A | USED TO INHIBIT PREMATURE VULCANIZATION OF RUBBERS | MONSANTO COMPANY (US) | 1981-07-28 | — | — | US | disclosed |
| US-4207216-A | HINDERED ALKYLTHIOIMIDAZOLIDINETRIONES | MONSANTO COMPANY (US) | 1980-06-10 | — | — | US | disclosed |
| US-3954997-A | MITICIDES, INSECTICIDES | THE UPJOHN COMPANY (US) | 1976-05-04 | — | — | US | disclosed |